1. Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis. (June 2022) Authors: Shahbar, Alaa; Alshamrani, Majed; Aseeri, Mohammed; Alfayea, Turki; Alnatsheh, Abdelmajid Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 4(2022) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗